Mazama Capital Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-101,207
| Closed | -$10.6M | – | 25 |
|
|
2015
Q4 | $10.6M | Buy |
101,207
+96,118
| +1,889% | +$10.1M | 1.95% | 6 |
|
|
2015
Q3 | $536K | Buy |
5,089
+1,030
| +25% | +$108K | 0.11% | 164 |
|
|
2015
Q2 | $555K | Sell |
4,059
-4,154
| -51% | -$568K | 0.11% | 174 |
|
|
2015
Q1 | $1.02M | Sell |
8,213
-2,518
| -23% | -$314K | 0.21% | 132 |
|
|
2014
Q4 | $970K | Sell |
10,731
-12,705
| -54% | -$1.15M | 0.22% | 134 |
|
|
2014
Q3 | $1.69M | Buy |
23,436
+9,259
| +65% | +$668K | 0.43% | 73 |
|
|
2014
Q2 | $881K | Buy |
14,177
+13,859
| +4,358% | +$861K | 0.24% | 110 |
|
|
2014
Q1 | $22K | Sell |
318
-20,567
| -98% | -$1.42M | 0.02% | 207 |
|
|
2013
Q4 | $1.47M | Hold |
20,885
| – | – | 0.73% | 52 |
|
|
2013
Q3 | $1.51M | Buy |
20,885
+9,158
| +78% | +$661K | 0.82% | 44 |
|
|
2013
Q2 | $654K | Buy |
+11,727
| New | +$654K | 0.41% | 94 |
|